Florian Engert is currently a Professor for Molecular and Cellular Biology at Harvard University. He received his PhD in 1997 from the Max Planck Institute for Neurobiology in Martinsried, Germany. In 2002, he became Assistant Professor of Neuroscience at Harvard University, where he became Associate Professor in 2006. Florian Engert has been a full professor since 2009. His laboratory works on establishing the larval zebrafish as a model system for visually induced behaviors and the underlying neuronal activity. Florian Engert was awarded the Janssen-Cilag Award for Young Investigators. He was awarded McKnight, Klingenstein, and Dana Research Fellowships and is a member of the Society for Neuroscience.
Scott C. Baraban is Professor of Neurological Surgery and William K. Bowes Jr. Endowed Chair in Neuroscience Research at the University of California, San Francisco (UCSF) where he directs an epilepsy research laboratory in the Department of Neurological Surgery. He received his PhD in Pharmacology from the University of Virginia (1990-94) and has been UCSF faculty since 1999. His NIH-funded research includes interneuron-based cell therapies, the first zebrafish models for epilepsy ever developed and the first high-throughput drug screen using a zebrafish model for Dravet syndrome. Prof Baraban’s research has earned multiple honors, including the Basil O’ Connor Scholar Research award, Klingenstein Fellowship, NIH EUREKA and Javits awards. He received the Basic Science Research Recognition award, the highest honor awarded to basic scientists by the American Epilepsy Society, in 2016.
The Department of Experimental and Health Sciences(DCEXS) was founded by Universitat Pompeu Fabra (UPF) and gives full support to the ZeClinics project.
The PRBB, one of the largest scientific infrastructures in Europe dedicated to biomedical research, offers the highest technological and networking platform to ensure the best quality of ZeClinics services
ABAC Therapeutics is committed to finding therapeutic solutions for patients that are infected with highly antibiotic-resistant bacterial pathogens and that leave affected patients with few (or no) treatment options.
The Centers for Networked Biomedical Research (CIBERNED) were established with a view to generate large translational research centers, multidisciplinary and multi-institutional, where to integrate basic, clinical and epidemiological research.
Pivot Park is the pivot in a flourishing network of companies and knowledge institutions involved, either directly or indirectly, in innovative life sciences research. Pivot Park provides an optimal infrastructure, state-of-the-art facilities and a wealth of knowledge and experience.
Taros’ drug discovery division is committed to accelerating potential new medicines into clinical development, adding considerable value to drug discovery collaborations by boosting collaborators’ discovery programs from target validation and hit identification to lead generation and optimization.
ZeClinics has received funding from the Ministry of Economy and Competitiveness for hiring researchers through the EMPLEA, Industrial Doctorates, and Torres Quevedo calls of the State Talent Promotion and Employability Program, included in the State Plan of Scientific Research, Technology and Innovation 2013-2016 and 2017-2020.
The University Pompeu Fabra Business Shuttle department guarantees the positioning of ZeClinics in the fascinating and dynamic business of the Catalan Bio Region.
The Germans Trias i Pujol Research Institute is a public research centre in the Autonomous region of Catalonia in Northern Spain dedicated to increasing scientific knowledge and transferring it to improve the care and lives of patients.
Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine, where the high-level basic research focuses and works on relevant clinical matters and fosters economic development.
Noldus Information Technology develops and delivers innovative software and hardware solutions and services for the measurement and analysis of behavior. These allow our customers to advance their research, product development, training, and education.
Cobo Scientific is a Biomedical company with focus on innovative and unique products and services within the BioMedical Research and Drug Discovery segments.
The purpose of Spanish Drug Discovery Network (SDDN) is to create a forum where professionals working in Spain in the discovery and development of new drugs to know each other better, exchange ideas and discuss new initiatives and trends in the sector.
Biocat is the catalan organization that coordinates and promotes the health and life sciences sector in Catalonia region. Its mission is to dynamize and support the public and private stakeholders that make up the BioRegion.
EuropaBio is the European Association for Bioindustries. They mission is to create an innovative and dynamic biotechnology-based industry in Europe. They are actively engaged in raising awareness of the benefits of biotechnology to all corners of society and to increase the knowledge and understanding of our industry.
EIT Health was established in 2015, as a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). Through his unique network of world-class healthcare organizations, EIT Health links entrepreneurial businesses with the knowledge and resources to scale up and scale out as quickly as possible. ‘EIT Health is supported by EIT, a body of the European Union’.
ASEBIO is the Spanish Bioindustry Association. ASEBIO brings together companies, associations, foundations, universities, research and technology centers that carry out activities directly or indirectly related to biotechnology in Spain.
It is the biotechnology platform that ASEBIO launched with the support of the Ministry of Economy and Competitiveness (MINECO), and with the collaboration of the Spanish Society of Biotechnology (SEBIOT).
CataloniaBio is the association of companies in the health and life sciences arena in Catalonia. Its mission is to represent and support companies interested in promoting a strategic, innovative cluster, as well as helping to define the framework for sector-wide actions and industrial policies established at a national and European level.